Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals

Experimental Hematology

Volumn 27, Issue 1, 1999, Pages 147-154

  Law, Ping ^a   Lane, Thomas A ^a   Gervaix, Alain ^a   Looney, David ^a   Schwarz, Lamia ^a   Young, Dennis ^a   Ramos, Silvestre ^a   Wong Staal, Flossie ^a   Recktenwald, Diether ^b   D Ho, Anthony ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AmCell Corporation   (United States)

Author keywords

Acquired immunodeficiency syndrome patients; CD34+ cells; Granulocyte colony; Mobilization; Stimulating factor

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD34; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV; HIV INFECTIONS; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, VIRAL; TIME FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033015244     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00023-X     Document Type: Article

References (46)

1. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., Ho D.D. HIV-1 dynamics in vivo. virion clearance rate, infected cell life-span, and viral generation time Science. 271:1996;1582.
2. Mo H., Markowitz M., Majer P., Burt S.K., Gulnik S.V., Suvorov L.I., Erickson J.W., Ho D.D. Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease. AIDS Res Hum Retrovir. 12:1996;55.
3. Richman D.D. Antiretroviral drug resistance. mechanism, pathogenesis, clinical significance Adv Exp Med Biol. 394:1996;383.
4. Molla A., Korneyeva M., Gao Q., Vasavanonda S., Schipper P.J., Mo H.M., Markowitz M., Chernyavskiy T., Niu P., Lyons N.et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med. 2:1996;760.
5. Bonyhadi M.L., Moss K., Voytovich A., Auten J., Kalfoglou C., Plavec I., Forestell S., Su L., Böhnlein E., Kaneshima H. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J Virol. 71:1997;4707-4716.
6. Lishan S., Lee R., Bonyhadi M., Matsuzaki H., Forestell S., Escaich S., Böhnlein E., Kaneshima H. Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome. Efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro Blood. 89:1997;2283-2290.
7. Yu M., Leavitt M.C., Maruyama M., Yamada O., Young D., Ho A.D., Wong-Staal F. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 92:1995;699.
8. Yu M., Ojwang J., Yamada O., Hampel A., Rapapport J., Looney D., Wong-Staal F. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;6340.
9. Woffendin C., Ranga U., Yang Z., Xu L., Nabel G.J. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc Natl Acad Sci USA. 93:1996;2889.
10. Lane T.A., Law P., Maruyama M., Young D., Burgess J., Mullen M., Mealiffe M., Terstappen L.W.M.M., Hardwick A., Moubayed M., Oldham F., Corringham R.E.T., Ho A.D. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF. potential role in allogeneic marrow transplantation Blood. 85:1995;275.
11. Korbling M., Prezepiorka D., Hugh Y.O., Engel H., Van Besien K., Giralt S., Anderson B., Kleine H.D., Seong D., Deisseroth A.B., Andreef M., Champlin R. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma. potential advantage of blood over marrow allografts Blood. 85:1995;1659.
12. +-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors. Blood. 86:1995;2052.
13. Ho A.D., Glück S., Germond C., Sinoff C., Dietz G., Maruyama M., Corringham R.E.T. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia. 17:1993;1738.
14. Kessinger A., Armitage J.O., Landmark J.D. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood. 71:1988;723.
15. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients. enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor Blood. 74:1989;1905.
16. To L.B., Haylock D.N., Kimber R.J., Juttner C.A. High levels of circulating haematopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopresevation. Br J Haematol. 58:1984;399.
17. Hartung T., Docke W.D., Gantner F., Krieger G., Sauer A., Stevens P., Volk H.D., Wendel A. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood. 85:1995;2482.
18. Huhn D.R., Yurkow E.J., Tushinski R., Clarke L., Sturgill M.G., Hoffman R., Sheay W., Cody R., Philipp C., Resta D., George M. Recombinant human IL-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol. 24:1996;839.
19. Marandin A., Katz A., Oksenhendler E., Tulliez M., Picard F., Vainchenker W., Louache F. Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood. 88:1996;4568.
20. Kitano K., Abboud C.N., Ryan D.H., Quan S.G., Baldwin G.C., Golde D.W. Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood. 77:1991;1699.
21. Koyangi Y., O'Brien W.A., Zhao J.Q., Golde D.W., Gassen J.C., Chen I.S. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science. 241:1988;1673.
22. Perno C.F., Cooney D.A., Gao W.Y., Hao Z., Johns D.G., Foli A., Hartman N.R., Calio R., Broder S., Yarchoan R. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures and monocyte/macrophages. Blood. 80:1992;995.
23. + progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults. Blood. 88:1996;3329.
24. + peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factor. Blood. 89:1997;4299.
25. Nielsen S.D., Dam-Larsen S., Nielsen C., Wantzia P., Mathiesen L., Hansen J.E. Recombinant human granulocyte colony-stimulating factor increases circulating CD34-positive cells in patients with AIDS. Ann Hematol. 74:1997;215.
26. Bender J.G., Unverzagt K.L., Walker D.E., Lee W., Van Epps D.E., Smith D.H., Stewart C.C., To L.B. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 77:1991;2591.
27. Todd J., Pachl C., White R., Yeghiazarian T., Johnson P., Taylor B., Holodniy M., Kern D., Hamren S., Chernoff M.et al. Performance characteristics for the quantitation of plasma HIV-1 RNA using branded DNA signal amplification technology. J Acq Imm Def Synd Hum Retrovirol. 10(suppl 2):1995;S35.
28. + subsets in leukapheresis products mobilized by GM-CSF vs. a combination of both. Exp Hematol. 24:1996;1460.
29. - hematopoietic stem cell. Blood. 83:1994;1515.
30. - progenitor cells. Blood. 77:1991;1218.
31. Ho A.D., Bashey A., Mason J., Corringham R.E.T., Mulroney C., Law P. Characterization of "poor mobilizers" in unselected group of autologous transplant candidates. Blood. 88(suppl 1):1996;405a. [abstr].
32. Nowak M.A., Anderson R.M., McLean A.R., Wolfs T.F., Goudsmit J., May R.M. Antigenic diversity thresholds and the development of AIDS. Science. 15:1991;963.
33. Stanley S.K., Ostrowski M.A., Justement J.S., Gantt K., Hedayati S., Mannix M., Roche K., Schwartzentruber D.J., Fox C.H., Fauci A.S. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med. 334:1996;1222.
34. Torbett B.E., Healy P.A., Shao L.E., Mosier D.E., Yu J. HIV-1 infection is latent in primary and transformed bone marrow stromal cells. Blood. 84(suppl 1):1994;480a. [abstr].
35. Isola L.M., Scigliano E., Skerrett D., Shank B., Ross V., Najfeld V., Fruchtman S. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant. 20:1997;1033.
36. + cell yield but causes delayed pancytopenia. Blood. 90:1997;375a. [abstr].
37. Kimura S., Matsuda J., Ikematsu S., Miyazono K., Ito A., Nakahata T., Minamitani M., Shimada K., Shiokawa Y., Takaku F. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. 1990;1251, AIDS.
38. + cells. Exp Hematol. 24:1996;738.
39. Knaän-Shanzer S., Valerio D., van Beusechem V.W. Cell cycle state, response to hemopoietic growth factors and retroviral vector-mediated transduction of human hemopoietic stem cells. Gene Ther. 3:1996;323.
40. Nolta J.A., Smogorzewska E.M., Kohn D.B. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood. 86:1995;101.
41. Young J.C., Varma A., DiGiusto D., Backer M.P. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood. 87:1996;545.
42. + hematopoietic stem cells of HIV-infected individuals. Hum Gene Ther. 8:1997;2229.
43. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by lentiviral vectors. Science. 272:1996;263.
44. Baum C.M., Weissmann I.L., Tsukamoto A.S., Buckle A.M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA. 89:1992;2804.
45. - subpopulation from mobilized peripheral blood. Blood. 85:1995;368.
46. - peripheral blood stem cells (PBSC) transplantation after high dose therapy for patients with multiple myeloma. Blood. 88(suppl 1):1996;595a. [abstr].